Appearance
Altria(奥驰亚) MO
PMTA (Premarket Tobacco Product Application) reviews
Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products.
In combustibles, we own
- Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and
- John Middleton Co. (Middleton), a leading U.S. cigar manufacturer.
Our smoke-free portfolio includes ownership of
- U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer,
- Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and
- NJOY, LLC (NJOY), an e-vapor manufacturer with products covered by marketing granted orders from the U.S. Food and Drug Administration (FDA).
Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products.
Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.
The brand portfolios of our operating companies includeMarlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®).
Investors
News
RICHMOND, Va.--(BUSINESS WIRE)-- Altria Group, Inc. (NYSE:MO) announces that we have entered into a definitive agreement to acquire NJOY Holdings, Inc. (NJOY) for approximately $2.75 billion in cash payable at closing (Transaction). The Transaction terms include additional $500 million in cash payments that are contingent upon regulatory outcomes with respect to certain NJOY products.
Earnings
2025Q3
In August, we announced our 60th dividend increase in 56 years, and yesterday, our Board authorized an expansion of our share repurchase program.
We are raising the lower-end of our 2025 full-year guidance and now expect to deliver adjusted diluted EPS in a range of $5.37 to $5.45. This range represents a growth rate of 3.5% to 5.0% from a base of $5.19 in 2024.
In the third quarter, we repurchased 1.9 million shares at an average price of $60.13, for a total cost of $112 million.
Through the first nine months, we repurchased 12.3 million shares at an average price of $58.08, for a total cost of $712 million.
Yesterday, our Board of Directors (Board) authorized the expansion of our existing share repurchase program from $1 billion to $2 billion, which now expires on December 31, 2026.
In August, our Board increased our regular quarterly dividend by 3.9%, marking the 60th increase in the past 56 years. Our current annualized dividend rate is $4.24 per share.
We maintain our progressive dividend goal that targets mid-single digits dividend per share growth annually through 2028.
2025Q2
“We are raising the lower-end of our 2025 full-year guidance and now expect to deliver adjusted diluted EPS in a range of $5.35 to $5.45. This range represents a growth rate of 3.0% to 5.0% from a base of $5.19 in 2024.”
In the second quarter, we repurchased 4.7 million shares at an average price of $58.63, for a total cost of $274million.
Through the first half, we repurchased 10.4 million shares at an average price of $57.71, for a total cost of $600 million
We paid dividends of $1.7 billion and $3.5 billion in the second quarter and first half, respectively.
2025Q1
On March 31, 2025, the ITC’s importation ban and cease-and-desist orders applicable to NJOY ACE (ACE) went into effect. While NJOY discontinued shipments of ACE to wholesalers as of March 24, 2025, retailers are permitted to sell through their existing inventory of ACE.
As a result of the ITC orders going into effect, we recorded a non-cash impairment charge of $873 million to the e-vapor reporting unit goodwill in the first quarter of 2025. There was no income tax benefit associated with the impairment because it is non-deductible for tax purposes.
JUUL’s patent litigation against NJOY has resulted in the U.S. International Trade Commission’s (ITC) issuing an exclusion order and cease-and-desist orders prohibiting the importation and sale of NJOY ACE (NJOY’s pod-based e-vapor product) in the U.S.